A Routine and Favorable Medical Update

A few weeks ago Dr. Myers slightly modified my treatment plan in response to a concern I expressed about a reduction in my potency.* In response, the reader may recall, Dr. Myers lowered my weekly intake of Casodex from three 50mm capsules to two. I am pleased to report this change achieved its goal. In addition my PSAs have remained low and stable as indicated below:
 March    .365
 April      .256
 June       .26
 July        .22
Looming on the horizon are the following two events:
--On October 22 I am scheduled for an endorectal MRI ordered by Dr. Myers to determine the status of the 1.1cm tumor in my prostate identified by Choline Scan at Mayo Clinic two years ago.
--On October 29 I will have my third (annual) appointment with  Dr. Myers.
Stay tuned.


*I also expressed concern about breast development and tenderness. There has been little if any improvement in this respect. Time permitting I intend to discuss this issue with Dr. Myers on October 29.

Could Be Something Could Be Nothing : Been There Done That : Well Then Welcome Back

The outcome of my full body bone scan is described below in an e-mail to my immediate family and a close friend:

"The radiologist's report reads in part: There is a localized area of increased uptake (of radionuclide) associated with the very posterior aspect of the 9th or 10th rib on the left. There is also a curvilinear increased uptake associated with the region of the trochanter(upper femur) on the left.

The radiologist verbally advised my primary physician, Dr. Hansen, that he detected no clear indication of metastasis. By phone Dr. Hansen explained  the suspicious areas could be the result of earlier bone trauma of one type or another, e. g., fractures or degeneration. In view of my Pca history neither the radiologist nor Dr. Hansen could rule out metastasis and recommended a full body scan six months from now. Incidentally these findings were supported by six standard x-ray views of the spine and pelvic region conducted subsequent to the full body scan."

As the long-term reader with a good memory will readily appreciate, it is not the first time this Pca warrior-veteran has been caught up between the devil and the deep blue sea. And in all likelihood, it will not  be the last.

The next order of business will be an endorectal MRI suggested by Dr. Myers at our most recent routine appointment. This should be completed within the next three or four weeks.

Good News Bad News(?) Edition

As reported in my prior entry Dr. Myers adjusted my treatment plan in response to the concerns I expressed about  reduced sexuality and increased breast tenderness/tissue deveopment  issues. He thought two 50 mg Casodex pills per week rather than three would restore my quality of life. Although too early to quantify, I am pleased to report improvement in both respects. Equally important, if not more so, my PSA continues to remain low and fairly stable as shown by the following data: March .365; April  .256; May .28.

The above good news is overshadowed by the events I describe in the following Patient Portal email to Dr. Myers: "By way of an update you should know that I have developed symptoms alarmingly consistent with Pca metastasis. These symptoms include acute pain in the lower left posterior of my rib cage brought about by vigorous physical activity (i. e., a competitive singles  tennis match). The pain has not subsided since its onset nearly two weeks ago. The affected area is fairly limited in size and scope, but is quite sensitive to pressure and movement. I have an appointment tomorrow with my family physician (a Pca survivor too).  I would appreciate any feedback you care to provide."

Dr. Myers responded  to my concerns  thusly: "Those would be very atypical for bone met symptoms, which rarely have an acute onset and rarely would be sensitive to touch. This is most likely a cracked rib.* A bone scan  and then an MRI of any abnormalities would be definitive." To which I replied: " Thank you so very much for the feedback. I could only hope that you might be willing to provide an opinion without having seen me. My doctor thought I did the right thing to come in for an examination because of my history. He arranged a total bone scan for  next Tuesday. I will keep you informed. Also, I will contact you regarding an MRI. You indicated when we last met that I should arrange a MRI screening prior to our next appointment."

Thankfully, the above exchange of emails drained the developing  drama of much of its momentum. Even so, as has been said in a great many contexts, "It's not over until it's over." Stay tuned.


*Comforting and plausible but wholly contrary to my online research effort.
.

Side Effects Lead to a Minor Change in My Treatment Plan

On March 6, I sent Dr. Myers the following e-mail via the patient portal:

" I have two concerns which I believe warrant your attention. The first of these we have discussed on more than one occasion, but continues to evolve.  My nipples remain quite sensitive and painful to pressure. A new, worrisome development (literally) consists of a checker-shaped and checker-sized disc beneath each nipple. Additionally there has been  a modest growth of soft tissue on either side, more so on the left than the right. I doubt  this condition is noticeable to others, but I need your help in determining when and if corrective action may be indicated.

The second concern involves my sexuality. Within the past four or five weeks there has been a dramatic reduction in my sexual potency.  For perspective if asked to quantify the loss, I would place the figure between  35 and 45 percent.

My top priorities are to arrest the progression of my cancer and extend the quality of my life for as long as possible. My questions are as follows:

--  Is there a change in my protocol that will enable my wife and I  to continue to "have our cake and eat it too?

 --. At age 78 is it time for us to accept the status quo? Is it time to thank our lucky stars that we have had such "a good long run?"

Your assistance on these matters would be particularly appreciated.

Any additional comments or suggestions you care to offer would be most welcome."*

On March 16 Dr. Myers responded as follows:

"Reduce your  dosage of Casodex from thrice weekly to twice a week. This change should help you with your quality of life."*

I would have preferred a more definitive answer. Rather than belabor the point, however,  I chose to interpret Dr. Myers'  response to mean that such a change may well (1) enable my wife and I to return to our customary level of cake eating activity, (2) suspend the progression of my cancer  and (3) stifle any further breast development.

 Accordingly I replied to his proposed treatment modification as shown below:

"I appreciate your responsiveness to these issues. I will make the change and monitor the results. Thanks again."*

***While most of the material in quotes is verbatim, I exercised my author's editorial prerogative here and there.

Hormone Lite: Results in the Short-term and a Brief Discussion of Long-term Prospects

With a PSA of 6.7 and rising, I implemented Dr. Myers' Hormone Lite treatment plan on November 11, 2013. Two weeks later my PSA dropped to 1.69. By late December my PSA descended further to .49. Thus far the only unambiguous side effect is sore-to-the-touch nipples. Their tenderness is certainly tolerable and more of a pesky distraction than anything else. Please be assured, however, I intend to closely monitor my general well-being for further developments.
With an eye on my future prospects, I used the Patient Portal to email  Dr. Myers as follows:

Based on your knowledge and experience, please address the following questions:
1, What is the likelihood that my cancer will become hormone refractory based on this protocol?

2. . The University of Michigan Health System issued a study in June of 2012 on survival rates for men undergoing androgen-deprivation therapy. Men on continuous therapy had a median overall survival time of 5.8 years, with 29 percent of these men surviving at least 10 years. In your opinion will "Hormone Lite" produce similar results?

Dr. Myers' response appears below:

Casodex and Avodart are given to arrest progression and cause a modest reduction in the number of cancer cells. Because it leaves your testosterone levels at a normal level, side effects are minimal. In cases like yours, I have seen it work for more than  a  decade, but sometimes progression is earlier.

When we do  full hormonal therapy including suppression of testosterone, our goal is to induce a complete remission. This is an aggressive therapy and must be done with careful attention to side effects. Once complete remission is attained, we stop full hormonal therapy and start a program to slow or arrest recurrent  disease. In that program Avodart, Statins, Metformin and diet are all key. 

The U of M data have no  relevance to your case. They have to do with wide spread metastatic cancer. Even so, these results represent yesterdays results and do not reflect any of the new drugs. Certainly, our results are radically better than this.

I turn 78 next month. If Dr. Myers' protocol maintains my existing quality of life for another 10 years or so, I will consider myself as one extremely fortunate fellow. Double lucky in fact. Double lucky indeed!

A Brief Retrospective Triggered by a Current Event

  A dear friend of mine was recently diagnosed with prostate cancer with a Gleason score of 6 (3+3) and a PSA of 6. By pure coincidence Dr. Easy performed my buddy's biopsy, and true to form recommended robotic surgery as  he did for me.. Longtime readers of this journal  may recall the entry regarding my appointment with Dr. Easy (see: A Definitive Diagnosis).

My friend and I  had a wide ranging telephone conversation during which we discussed the value of (1) Bob Marckini's book, "You Can Beat Prostate Cancer,"(2) the need to conduct one's own research in general and (3) the increased risk of surgery as we grow older. My friend turns 70 next month.

  A follow up  email appears below:

Chuck:

"I cannot over emphasize the importance of research at this point. Not only will it enhance your chances of making a good decision for yourself, but it will enable you to ask good questions as you encounter various practitioners along the way. For upcoming meetings with practitioners as a matter of routine I prepare a list of (written) questions to which I want answers-- although I let the session evolve based on the purpose of the appointment. I think it is important to  hear the guy/gal out before steering the discussion. Toward the end of our meeting I raise my questions if they have not already been addressed.

FYI   Following my diagnosis I placed great emphasis on survival, i.e., extending my existence. Over time, when I realized I might be around a while longer, my priority changed to preserving my quality of life."

My friend's  regrettable  diagnosis  provided this opportunity to summarize a few  of the important lessons I learned during my tumultuous journey. I thought it may be of interest to those of you who have been tracking my progress

A New Prescription Plus a Few Questions and Answers

Dr.. Myers makes himself available to his patients via an Internet "Patient Portal." Patients are able to raise questions about their treatment at anytime. Likewise he communicates with his patients at will. The following Patient Portal exchange (1) introduces a new medication to my treatment plan, and (2) provides a snapshot of Dr. Myers' approach to the treatment of prostate cancer.

Pt.: Why did Avodart appear to work so well for the first four months of treatment then cease to be effective? .

Dr.:Recent studies have shown that prostate cancer can overcome Avodart and even Casodex by picking up LDL cholesterol and converting it to dihydrotestosteron. By lowering your LDL with a statin we can block this. I added low dose Simvastatin (Zucor) to your program. This statin has powerful anti-inflammatory activity and very low risk of side effects,

Pt.:  If Simvastatin effectively controls the progression of my cancer, the Casodex and Metformin may not be needed at this time. If the Simvastatin has little or no effect on the progression, it may not be needed, Do we dare experiment for a month or so?

 Dr.: Cancer is complex and adapts rapidly. This is more difficult if the cancer is attacked from different angles at the same time. If you have 3 drugs each with a 1/100 odds of resistance, the odds of resistance to all three are 1/100x1/100x1/100 which equals one in a million. This is why cancer, tuberculosis and AIDS are all treated with combinations

Pt.: Is "Hormone Lite" likely to  become hormone resistant? If so, when?

Dr.: Sometimes, usually after several years.

Pt.:  Am I now or am I likely to become a candidate for chemo-therapy? Is this an alternative we should have discussed on the 29th?

Dr.: Highly unlikely.

Pt.: What percentage of us on Casodex will experience gynecomastia? Is breast tenderness a precursor to gynecomestia? I believe you indicated these symptoms, if they occur, do not show up for about two years. If I recall you advised me we could address these issues when and if they occur. Does this mean preventive action, e. g., radiation, is contraindicated?

Dr.: It develops very gradually with plenty of time to do something about it..

 Pt.:Are these the only side effects that are likely to occur? .

Dr.: Yes

These questions and answers are virtually verbatim. I exercised editorial prerogative here and there to achieve clarity and continuity.

Stay tuned.